Kiniksa Pharmaceuticals International, plc Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Kiniksa Pharmaceuticals International, plc (KNSA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $9.75 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-24
- Kiniksa Pharmaceuticals International, plc valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2022-12-31 was $348.00K.
- Kiniksa Pharmaceuticals International, plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $9.75M, a 98.40% decline from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $610.45M, a 2188.39% increase from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $26.68M.
- Kiniksa Pharmaceuticals International, plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$185.50M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|---|
| 2025-12-31 | $9.75M 10-K · filed 2026-02-24 | ||
| 2024-12-31 | $610.45M 10-K · filed 2026-02-24 | ||
| 2023-12-31 | $26.68M 10-K · filed 2025-02-25 | ||
| 2022-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$185.50M 10-K · filed 2023-03-02 | |
| 2022-09-30 | -$185.84M 10-Q · filed 2022-11-03 | ||
| 2019-12-31 | $281.00K 10-K · filed 2020-03-05 | ||
| 2018-12-31 | $22.00K 10-K · filed 2019-03-12 | ||
| 2017-12-31 | $17.00K 10-K · filed 2019-03-12 |